TOCILIZUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 75 adverse event reports in the FDA FAERS database where TOCILIZUMAB was used for Psoriasis.
Most Reported Side Effects for TOCILIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 32,342 | 32.9% | 1,812 | 6,486 |
| Rheumatoid arthritis | 20,652 | 21.0% | 2,125 | 5,176 |
| Pain | 18,384 | 18.7% | 1,939 | 4,934 |
| Off label use | 18,256 | 18.5% | 3,347 | 5,844 |
| Arthralgia | 15,536 | 15.8% | 1,996 | 4,784 |
| Joint swelling | 14,831 | 15.1% | 2,093 | 4,081 |
| Fatigue | 13,802 | 14.0% | 2,217 | 4,295 |
| Rash | 12,327 | 12.5% | 2,019 | 4,046 |
| Drug intolerance | 11,952 | 12.1% | 1,587 | 3,341 |
| Contraindicated product administered | 11,547 | 11.7% | 1,409 | 3,008 |
| Arthropathy | 9,816 | 10.0% | 1,774 | 3,868 |
| Alopecia | 9,680 | 9.8% | 1,726 | 2,784 |
| Abdominal discomfort | 9,553 | 9.7% | 1,715 | 2,821 |
| Synovitis | 9,428 | 9.6% | 1,890 | 3,599 |
| Swelling | 9,420 | 9.6% | 1,850 | 2,910 |
Other Indications for TOCILIZUMAB
Rheumatoid arthritis (55,449)
Product used for unknown indication (21,090)
Giant cell arteritis (4,364)
Covid-19 (4,186)
Juvenile idiopathic arthritis (2,016)
Covid-19 pneumonia (1,583)
Still's disease (1,418)
Temporal arteritis (1,269)
Polymyalgia rheumatica (964)
Cytokine release syndrome (735)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)